Evelyn Partners Investment Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.51M Sell
29,494
-1,405
-5% -$125K 0.07% 96
2025
Q4
$2.44M Sell
30,899
-1,893
-6% -$148K 0.07% 97
2025
Q3
$2.62M Sell
32,792
-1,269
-4% -$108K 0.07% 94
2025
Q2
$3.1M Sell
34,061
-580
-2% -$52.9K 0.09% 89
2025
Q1
$3.25M Sell
34,641
-263
-0.8% -$23.6K 0.11% 85
2024
Q4
$3.17M Buy
+34,904
New +$3.33M 0.1% 83

Other funds holding CL

Evelyn Partners Investment Management's CL Position: Q1 2026 in Review

Evelyn Partners Investment Management reduced its Colgate-Palmolive (CL) stake by 4.5% in Q1 2026, selling an estimated $125K and leaving 29,494 shares worth $2.51M. The position accounts for 0.07% of the portfolio, ranked #96.

Evelyn Partners Investment Management first reported a position in CL in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.25M in Q1 2025. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Evelyn Partners Investment Management held 29,494 shares of Colgate-Palmolive worth $2.51M as of Q1 2026.
  • Evelyn Partners Investment Management sold 1,405 Colgate-Palmolive shares in Q1 2026, an estimated $125K.
  • Colgate-Palmolive made up 0.07% of Evelyn Partners Investment Management's portfolio in Q1 2026, its #96 holding.
  • Evelyn Partners Investment Management first reported a position in Colgate-Palmolive in Q4 2024 and has held it in 6 quarters since.
  • Evelyn Partners Investment Management's Colgate-Palmolive position peaked at $3.25M in Q1 2025.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Evelyn Partners Investment Management's 13F filing for Q1 2026, filed 15 May 2026.